Hanmi Pharm Successfully Concludes Open Innovation Event with Kiwoom Securities
Over 80 Industry Experts Participate
Hanmi Pharm successfully hosted an open innovation event designed to connect bio ventures with investors.
Hanmi Pharm announced on the 16th that, together with Kiwoom Securities, it held the 'Hanmi x Kiwoom Bio Innovation Day' at Hanmi C&C Square in Songpa-gu, Seoul, the previous day.
Hanmi Pharmaceutical and Kiwoom Securities held the "Hanmi x Kiwoom Bio Innovation Day" on the 15th at Hanmi C&C Square in Songpa-gu, Seoul. Hanmi Pharmaceutical
View original imageThe event featured IR presentations from 10 domestic bio ventures and offered one-on-one meetings between participating companies and investors. More than 80 key figures from the pharmaceutical and biotech industry—including promising domestic bio ventures, venture capital firms (VC), private equity funds (PE), securities companies, and strategic investors (SI)—attended, sharing innovative technologies and market potential while seeking tangible investment and business cooperation opportunities.
Hanmi Pharm plans to further develop this event into an open innovation platform in the pharmaceutical and biotech industry, continuously connecting promising bio ventures with investors.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Hanmi Pharm CEO Hwang Sangyeon stated, "The competitiveness of the bio industry is further strengthened when the creative ideas of bio ventures and academia are organically linked with the research and development (R&D) and commercialization capabilities of the pharmaceutical industry." He added, "I hope this event serves as a touchpoint of trust between companies and investors, building a foundation for collaboration and leading to follow-up discussions."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.